Randomized phase III trial of erlotinib vs. docetaxel in patients with advanced squamous cell non-small cell lung cancer (SqNSCLC) failing first line platinum based doublet chemotherapy stratified by VeriStrat Good vs VeriStrat Poor: The European Thoracic Oncology Platform (ETOP) EMPHASIS trial.
2015 ◽
Vol 33
(15_suppl)
◽
pp. 8049-8049
Keyword(s):
2017 ◽
Vol 12
(4)
◽
pp. 752-762
◽
Keyword(s):
2007 ◽
Vol 2
(8)
◽
pp. S693-S694
Keyword(s):
Keyword(s):
2008 ◽
Vol 26
(15_suppl)
◽
pp. 8016-8016
◽
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. 7551-7551
◽
Keyword(s):
2013 ◽
Vol 31
(15_suppl)
◽
pp. 7507-7507
◽
Keyword(s):
Keyword(s):
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7504-7504
◽
Keyword(s):
2016 ◽
Vol 34
(15_suppl)
◽
pp. TPS8578-TPS8578
◽
Keyword(s):
Keyword(s):